Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 3 | 9 |
| List of Tables | 6 | 3 |
| List of Figures | 9 | 3 |
| Clinical Trial Recruitment in Central Nervous System Disorders - Introduction | 12 | 2 |
| GBI Research Report Guidance | 13 | 1 |
| Clinical Trials Overview | 14 | 10 |
| Clinical Trials Share by Therapeutic Area | 14 | 7 |
| Clinical Trials by Pharmaceutical Companies, 2005-2010 | 21 | 1 |
| Clinical Trials and Patient Recruitment in CNS | 22 | 2 |
| Clinical Trials and Patient Recruitment for Alzheimer s Disease | 24 | 14 |
| Introduction | 24 | 1 |
| Clinical Trials for Alzheimer s Disease | 25 | 1 |
| Number of Clinical Trials by Stage of Development | 25 | 1 |
| Number of Clinical Trials by Sponsor | 26 | 1 |
| Number of Clinical Trials by Geography | 27 | 1 |
| Number of Clinical Trials by Year | 28 | 1 |
| Prevalence Population for Alzheimer s disease (2010-2017) | 29 | 1 |
| Brazil | 29 | 1 |
| India | 30 | 1 |
| China | 31 | 1 |
| Patient Recruitment for Alzheimer s Disease | 32 | 1 |
| Number of Patients Recruited by Stage of Development | 32 | 1 |
| Number of Patients Recruited by Sponsor | 33 | 1 |
| Number of Patients Recruited by Geography | 34 | 1 |
| Number of Patients Recruited Per Year | 35 | 1 |
| Average Number of Patients Recruited Per Trial | 36 | 1 |
| Average Number of Patients Recruited Per Trial by Stage of Development | 36 | 1 |
| Average Number of Patients Recruited Per Trial Per Year | 37 | 1 |
| Clinical Trials and Patient Recruitment for Parkinson s Disease | 38 | 14 |
| Introduction | 38 | 1 |
| Clinical Trials for Parkinson s Disease | 39 | 1 |
| Number of Clinical Trials by Stage of Development | 39 | 1 |
| Number of Clinical Trials by Sponsor | 40 | 1 |
| Number of Clinical Trials by Geography | 41 | 1 |
| Number of Clinical Trials by Year | 42 | 1 |
| Prevalence Population for Parkinson s disease (2010-2017) | 43 | 1 |
| Brazil | 43 | 1 |
| India | 44 | 1 |
| China | 45 | 1 |
| Patient Recruitment for Parkinson s Disease | 46 | 1 |
| Number of Patients Recruited by Stage of Development | 46 | 1 |
| Number of Patients Recruited by Sponsor | 47 | 1 |
| Number of Patients Recruited by Geography | 48 | 1 |
| Number of Patients Recruited Per Year | 49 | 1 |
| Average Number of Patients Recruited Per Trial | 50 | 1 |
| Average Number of Patients Recruited Per Trial by Stage of Development | 50 | 1 |
| Average Number of Patients Reruited per Trial per Year | 51 | 1 |
| Clinical Trials and Patient Recruitment for Epilepsy | 52 | 14 |
| Introduction | 52 | 1 |
| Clinical Trials for Epilepsy | 53 | 1 |
| Number of Clinical Trials by Stage of Development | 53 | 1 |
| Number of Clinical Trials by Sponsor | 54 | 1 |
| Number of Clinical Trials by Geography | 55 | 1 |
| Number of Clinical Trials by Year | 56 | 1 |
| Prevalence Population for Epilepsy (2010-2017) | 57 | 1 |
| Brazil | 57 | 1 |
| India | 58 | 1 |
| China | 59 | 1 |
| Patient Recruitment for Epilepsy | 60 | 1 |
| Number of Patients Recruited by Stage of Development | 60 | 1 |
| Number of Patients Recruited by Sponsor | 61 | 1 |
| Number of Patients Recruited by Geography | 62 | 1 |
| Number of Patients Recruited Per Year | 63 | 1 |
| Average Number of Patients Recruited Per Trial | 64 | 1 |
| Average Number of Patients Recruited Per Trial by Stage of Development | 64 | 1 |
| Average Number of Patients Recruited Per Trial Per Year | 65 | 1 |
| Clinical Trials and Patient Recruitment for Schizophrenia | 66 | 14 |
| Introduction | 66 | 1 |
| Clinical Trials for Schizophrenia | 67 | 1 |
| Number of Clinical Trials by Stage of Development | 67 | 1 |
| Number of Clinical Trials by Sponsor | 68 | 1 |
| Number of Clinical Trials by Geography | 69 | 1 |
| Number of Clinical Trials by Year | 70 | 1 |
| Prevalence Population for Schizophrenia (2010-2017) | 71 | 1 |
| Brazil | 71 | 1 |
| India | 72 | 1 |
| China | 73 | 1 |
| Patient Recruitment for Schizophrenia | 74 | 1 |
| Number of Patients Recruited by Stage of Development | 74 | 1 |
| Number of Patients Recruited by Sponsor | 75 | 1 |
| Number of Patients Recruited by Geography | 76 | 1 |
| Number of Patients Recruited Per Year | 77 | 1 |
| Average Number of Patients Recruited Per Trial | 78 | 1 |
| Average Number of Patients Recruited Per Trial by Stage of Development | 78 | 1 |
| Average Number of Patients Recruited Per Trial Per Year | 79 | 1 |
| Clinical Trials and Patient Recruitment for Depression | 80 | 14 |
| Introduction | 80 | 1 |
| Clinical Trials for Depression | 81 | 1 |
| Number of Clinical Trials by Stage of Development | 81 | 1 |
| Number of Clinical Trials by Sponsor | 82 | 1 |
| Number of Clinical Trials by Geography | 83 | 1 |
| Number of Clinical Trials by Year | 84 | 1 |
| Prevalence Population for Depression (2010-2017) | 85 | 1 |
| Brazil | 85 | 1 |
| India | 86 | 1 |
| China | 87 | 1 |
| Patient Recruitment for Depression | 88 | 1 |
| Number of Patients Recruited by Stage of Development | 88 | 1 |
| Number of Patients Recruited by Sponsor | 89 | 1 |
| Number of Patients Recruited by Geography | 90 | 1 |
| Number of Patients Recruited Per Year | 91 | 1 |
| Average Number of Patients Recruited Per Trial | 92 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 92 | 1 |
| Average Number of Patients Recruited per Trial per Year | 93 | 1 |
| Clinical Trials Recruitment in Central Nervous System: Appendix | 94 | 4 |
| Market Definitions | 94 | 1 |
| Abbreviations | 94 | 1 |
| Research Methodology | 94 | 3 |
| Coverage | 94 | 1 |
| Secondary Research | 95 | 1 |
| Primary Research | 95 | 1 |
| Expert Panel Validation | 95 | 1 |
| Section-wise methodology | 95 | 1 |
| Clinical Trials Overview | 96 | 1 |
| Number of Clinical Trials | 96 | 1 |
| Patient Recruitment Status | 96 | 1 |
| Prevalence of Disease in India, China and Brazil (2010-2017) | 96 | 1 |
| Contact Us | 97 | 1 |
| Disclaimer | 97 | 1 |
| Sources | 97 | 1 |